EMEA-001324-PIP01-12-M01
Key facts
| Active substance |
glibenclamide
|
| Therapeutic area |
Other
|
| Decision number |
P/0072/2015
|
| PIP number |
EMEA-001324-PIP01-12-M01
|
| Pharmaceutical form(s) |
Oral suspension
|
| Condition(s) / indication(s) |
Treatment of neonatal diabetes mellitus
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AMMTeK
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|